 | • レポートコード：MRC2304A086 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、258ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の当調査レポートでは、2021年に421.23百万ドルであった世界の人工角膜＆角膜インプラント市場規模が2022年に471.69百万ドルへと拡大、更に2027年までにCAGR 12.23％で成長して841.95百万ドルに達すると予測しています。当書は、人工角膜＆角膜インプラントの世界市場を総合的に分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、種類別分析（人工角膜、ヒト角膜）、疾患別分析（フックスジストロフィー、真菌性角膜炎、円錐角膜）、移植種類別分析（内皮角膜形成術、全層角膜移植）、エンドユーザー別分析（病院、専門クリニック＆外来手術センター）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの構成でまとめています。なお、当書には、Addition Technology, Inc.、Advancing Sight Network、AJL Ophthalmic S.A.、Aurolab、Bausch & Lomb Incorporated、Bayer AG、Cornea Biosciences、CorneaGen Inc.、DIOPTEX GmbH、EyeYon Medical、F. Hoffmann-La Roche Ltd.、Florida Lions Eye Bankなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の人工角膜＆角膜インプラント市場規模：種類別 - 人工角膜の市場規模 - ヒト角膜の市場規模 ・世界の人工角膜＆角膜インプラント市場規模：疾患別 - フックスジストロフィーにおける市場規模 - 真菌性角膜炎における市場規模 - 円錐角膜における市場規模 ・世界の人工角膜＆角膜インプラント市場規模：移植種類別 - 内皮角膜形成術の市場規模 - 全層角膜移植の市場規模 ・世界の人工角膜＆角膜インプラント市場規模：エンドユーザー別 - 病院における市場規模 - 専門クリニック＆外来手術センターにおける市場規模 ・世界の人工角膜＆角膜インプラント市場規模：地域別 - 南北アメリカの人工角膜＆角膜インプラント市場規模 アメリカの人工角膜＆角膜インプラント市場規模 カナダの人工角膜＆角膜インプラント市場規模 ブラジルの人工角膜＆角膜インプラント市場規模 ... - アジア太平洋の人工角膜＆角膜インプラント市場規模 日本の人工角膜＆角膜インプラント市場規模 中国の人工角膜＆角膜インプラント市場規模 インドの人工角膜＆角膜インプラント市場規模 韓国の人工角膜＆角膜インプラント市場規模 台湾の人工角膜＆角膜インプラント市場規模 ... - ヨーロッパ/中東/アフリカの人工角膜＆角膜インプラント市場規模 イギリスの人工角膜＆角膜インプラント市場規模 ドイツの人工角膜＆角膜インプラント市場規模 フランスの人工角膜＆角膜インプラント市場規模 ロシアの人工角膜＆角膜インプラント市場規模 ... - その他地域の人工角膜＆角膜インプラント市場規模 ・競争状況 ・企業情報 |
The Global Artificial Cornea & Corneal Implant Market size was estimated at USD 421.23 million in 2021 and expected to reach USD 471.69 million in 2022, and is projected to grow at a CAGR 12.23% to reach USD 841.95 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Artificial Cornea & Corneal Implant to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the market was studied across Artificial Cornea and Human Cornea.
Based on Disease Indication, the market was studied across Fuchs’ Dystrophy, Fungal Keratitis, and Keratoconus.
Based on Transplant Type, the market was studied across Endothelial Keratoplasty and Penetrating Keratoplasty.
Based on End User, the market was studied across Hospitals and Specialty Clinics & Ambulatory Surgical Centers.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Artificial Cornea & Corneal Implant market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Artificial Cornea & Corneal Implant Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Artificial Cornea & Corneal Implant Market, including Addition Technology, Inc., Advancing Sight Network, AJL Ophthalmic S.A., Aurolab, Bausch & Lomb Incorporated, Bayer AG, Cornea Biosciences, CorneaGen Inc., DIOPTEX GmbH, EyeYon Medical, F. Hoffmann-La Roche Ltd., Florida Lions Eye Bank, L V Prasad Eye Institute, LinkoCare Life Sciences AB, Massachusetts Eye and Ear, Mediphacos, Pfizer, Inc., Presbia plc, San Diego Eye Bank, and SightLife.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Artificial Cornea & Corneal Implant Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Artificial Cornea & Corneal Implant Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Artificial Cornea & Corneal Implant Market?
4. What is the competitive strategic window for opportunities in the Global Artificial Cornea & Corneal Implant Market?
5. What are the technology trends and regulatory frameworks in the Global Artificial Cornea & Corneal Implant Market?
6. What is the market share of the leading vendors in the Global Artificial Cornea & Corneal Implant Market?
7. What modes and strategic moves are considered suitable for entering the Global Artificial Cornea & Corneal Implant Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rapid growth in geriartic population in the developing economies
5.1.1.2. Surge in government initiatives to control the increase in vision impairment
5.1.1.3. Rising prevalence of corneal infections and diseases among the children
5.1.2. Restraints
5.1.2.1. Shortage of skilled ophthalmologists in developing economies
5.1.3. Opportunities
5.1.3.1. Emergence of new technologies and advancements in implantation procedures
5.1.3.2. Increasing incidences of corneal donors in the developing economies
5.1.3.3. Higher budget among end-users for the adoption of ophthalmic devices
5.1.4. Challenges
5.1.4.1. Concerns regarding high risk in the grafting artificial cornea implant
5.2. Cumulative Impact of COVID-19
6. Artificial Cornea & Corneal Implant Market, by Type
6.1. Introduction
6.2. Artificial Cornea
6.3. Human Cornea
7. Artificial Cornea & Corneal Implant Market, by Disease Indication
7.1. Introduction
7.2. Fuchs’ Dystrophy
7.3. Fungal Keratitis
7.4. Keratoconus
8. Artificial Cornea & Corneal Implant Market, by Transplant Type
8.1. Introduction
8.2. Endothelial Keratoplasty
8.3. Penetrating Keratoplasty
9. Artificial Cornea & Corneal Implant Market, by End User
9.1. Introduction
9.2. Hospitals
9.3. Specialty Clinics & Ambulatory Surgical Centers
10. Americas Artificial Cornea & Corneal Implant Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Artificial Cornea & Corneal Implant Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Artificial Cornea & Corneal Implant Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Addition Technology, Inc.
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Advancing Sight Network
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. AJL Ophthalmic S.A.
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Aurolab
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Bausch & Lomb Incorporated
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Bayer AG
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Cornea Biosciences
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. CorneaGen Inc.
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. DIOPTEX GmbH
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. EyeYon Medical
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. F. Hoffmann-La Roche Ltd.
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Florida Lions Eye Bank
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. L V Prasad Eye Institute
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. LinkoCare Life Sciences AB
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Massachusetts Eye and Ear
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Mediphacos
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Pfizer, Inc.
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Presbia plc
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. San Diego Eye Bank
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. SightLife
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing